Related Experiment Video
Updated: Aug 4, 2025

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Sharps injuries with Lovenox and generic enoxaparin prefilled safety syringes: A 12-year retrospective
Terry Grimmond1, Maryann Gruden, Bobbi Jo Hurst
1Terry Grimmond is the director of Grimmond and Associates, Microbiology Consultancy in New Zealand; MaryAnn Gruden is an occupational health consultant in McMurray, Pa.; Bobbi Jo Hurst is an employee health and infection control RN at Orthopedic Associates of Lancaster in New Holland, Pa.; and Lydia F. Crutchfield is the President Emeritus of the Association of Occupational Health Professionals in Healthcare in Charlotte, N.C.
Purpose:
Investigate the incidence and mechanisms of sharps injuries (SI) to staff using Lovenox and generic enoxaparin prefilled syringes.
Methods:
Four national adverse event databases were examined over a 12-year period for incidence and brands involved with injury events to staff using enoxaparin prefilled syringes.
Results:
The search revealed 581 adverse events (including 20 sharps injuries) associated with device malfunction in 8 of 16 brands, with one brand mentioned significantly more frequently than others. No national alert had been issued.
Conclusions:
Use of certain brands of enoxaparin prefilled syringes poses a small but serious risk of injury to staff. Conducting root cause analyses on all SI is essential, as is the need for regularly evaluating safer devices, reporting all device incidents, enabling simpler reporting of adverse events, and establishing more effective intervention by FDA and manufacturers.
More Related Videos
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

